Wuhan Humanwell Healthcare (Group) Company Limited (600079) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Wuhan Humanwell Healthcare (Group) Company Limited Company Snapshot

Business Description:

Wuhan Humanwell Healthcare (Group) Company Limited operates in the Medicinals and botanicals sector. Wuhan Humanwell Healthcare (Group) Co., Ltd is principally engaged in pharmaceutical and real estate industries. The Company mainly provides medicines and condoms. The Company's medicine products mainly include family planning medicines, biological medicines, Uyghur medicines, western medicines, drugs of special control, bulk drugs and Chinese patent drugs. The Company also involves in property development and distribution. During the year ended December 31, 2010, the Company obtained approximately 82% and 12.65% of its total revenue from the pharmaceutical and property businesses, respectively. It distributes its products in domestic and overseas markets. In our complete report available for purchase the company is compared to: Shandong Lukang Pharmaceutical, Jiangzhong Pharmaceutical Company Limited and Livzon Pharmaceutical Group Incorporated.

Wuhan Humanwell Healthcare (Group) Company Limited

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 18.04
(Figures in Chinese Renmimbi)

1 Week	n/a	13 Weeks	1.5%

4 Weeks	-19.9%	52 Weeks	-22.2%

Wuhan Humanwell Healthcare (Group) Company Limited Key Data:

Ticker:	600079	Country:	CHINA

Exchanges:	SHG	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	2,204,799,000 (Year Ending Jan 2011).	Employees:	3,656

Currency:	Chinese Renmimbi	Market Cap:	8,901,723,193

Fiscal Yr Ends:	December	Shares Outstanding:	493,443,636

Share Type:	A Gu	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.